10-K

Company

Moleculin Biotech, Inc.

Filed

March 19, 2020

Period of Report

December 31, 2019

Accession Number

0001659617-20-000066

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →